Today: 9 June 2026
Browse Category

SGX:U11 22 January 2026 - 16 April 2026

Singapore Stock Market Today: STI Slips Despite Asia Rally as Banks Drag, Olam Jumps

Singapore Stock Market Today: STI Slips Despite Asia Rally as Banks Drag, Olam Jumps

Singapore’s Straits Times Index fell 0.27% to 5,007.83 on Thursday, weighed by declines in DBS, OCBC, UOB, and Singtel. Olam surged nearly 8% after clearing the last hurdle for its Olam Agri sale. The STI lagged regional peers as Japan’s Nikkei 225 and Hong Kong’s Hang Seng both advanced. Singapore’s economy remains sensitive to higher import costs and supply disruptions despite recent GDP growth.
Singapore Stock Market Today: STI Slides as Oil Surge Hits Banks and Airlines

Singapore Stock Market Today: STI Slides as Oil Surge Hits Banks and Airlines

Singapore’s Straits Times Index fell 2.3% to 4,736.98 by mid-afternoon Monday, after dropping as low as 4,697.52. Oil prices surged, with Brent crude hitting $119.50 a barrel, fueling inflation fears and delaying expectations for a U.S. Fed rate cut. Banks and travel stocks led losses, while oil and gas shares rallied. Regional markets saw heavier losses, with South Korea’s Kospi down 8% and Japan’s Nikkei off 6.5%.
Singapore shares end week near 5,000 after record touch, with earnings and global risk in focus

Singapore shares end week near 5,000 after record touch, with earnings and global risk in focus

Singapore’s Straits Times Index closed Friday at 4,995.07, up 0.6% for the day but down 0.4% for the week after hitting a record 5,041.33 on Monday. Yangzijiang Shipbuilding rose 10.7% while Venture Corp fell 7.5%. Investors focused on late earnings, dividend signals from banks, and global risk cues. Singapore’s official foreign reserves update is expected by March 9.
UOB share price ticks up in Singapore as traders size up Feb 24 earnings after DBS flags rate headwinds

UOB share price ticks up in Singapore as traders size up Feb 24 earnings after DBS flags rate headwinds

UOB shares rose 0.47% to S$38.88 in afternoon trading Tuesday ahead of its Feb. 24 results. DBS shares fell after reporting a 10% drop in Q4 profit and warning of a volatile 2026. Singapore raised its 2026 GDP forecast to 2–4% following 6.9% Q4 growth, while the central bank said inflation is tracking forecasts. Investors are watching UOB’s net interest margin, fee income, and credit costs.
iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings

UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings

United Overseas Bank shares edged up 0.13% to S$38.48 in afternoon trading Wednesday, with about 796,000 shares changing hands. The stock traded between S$38.18 and S$38.49, near its 52-week high of S$39.50. UOB’s next results are due February 24, with investors focused on net interest margin guidance and dividend signals. Market value stands at about S$63.5 billion.
UOB share price slips into weekend: what investors watch next for United Overseas Bank stock

UOB share price slips into weekend: what investors watch next for United Overseas Bank stock

United Overseas Bank shares fell 1% to S$38.27 Friday, tracking a broader dip in Singapore’s Straits Times Index after Wall Street losses. The Monetary Authority of Singapore left policy unchanged but raised its 2026 inflation outlook, citing upside risks. UOB’s consensus target price rose to S$37.26, while investors await full-year results on Feb. 24 for updates on margins and credit costs.
31 January 2026
UOB stock price wobbles after JPMorgan downgrade as MAS review and earnings near

UOB stock price wobbles after JPMorgan downgrade as MAS review and earnings near

UOB shares slipped 0.3% to S$38.40 by mid-afternoon in Singapore, lagging DBS and OCBC as the Straits Times Index rose 1%. JPMorgan downgraded UOB to “underweight” last week, while Macquarie upgraded it to “outperform.” Analysts expect Q4 net profit to fall 16.7% year-on-year to S$1.28 billion, citing weaker fees and a tough comparison base. UOB will report full-year results on Feb. 24.
DBS share price ticks up as Singapore bank rally rolls on; what to watch next

DBS share price ticks up as Singapore bank rally rolls on; what to watch next

DBS shares closed up 1.15% at S$58.75 on Friday, trailing gains in UOB and OCBC, which pushed the Straits Times Index to record highs. Macquarie Capital rated DBS “underperform” with a S$50 target, citing limited upside and exposure to Hong Kong property risks. DBS plans to redeem A$300 million in subordinated notes in April 2026, pending regulatory approval. Investors await policy updates from MAS on Jan. 29 and DBS earnings on Feb. 9.
23 January 2026
OCBC share price jumps near record in Singapore bank rally — what to watch next

OCBC share price jumps near record in Singapore bank rally — what to watch next

OCBC shares climbed about 3% to S$21.21 in afternoon trading, extending a rally among Singapore banks after broker upgrades and bets on delayed U.S. rate cuts. The bank announced a new securities financing unit targeting institutional clients, ahead of its Feb. 25 earnings release. OCBC also used 29,246 treasury shares for employee schemes, leaving 10.8 million on hand.
23 January 2026
1 2 3 4

Stock Market Today

  • Great Western Mining Issues TR-1 Major Shareholder Disclosure
    June 9, 2026, 10:36 AM EDT. Great Western Mining (GWMOF) announced a TR-1 notification of major holdings on June 9, 2026, via the Regulatory News Service (RNS) in Dublin. This disclosure highlights significant shareholdings in the company, providing investors with transparency on ownership stakes. The official document detailing the holdings is accessible via the London Stock Exchange website, ensuring market participants can review the full data. Such filings comply with regulatory requirements to keep the market informed of notable shareholder positions and maintain market integrity. The TR-1 form is a standard channel for reporting these substantial holdings in UK-listed companies.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop